Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future

Bone Marrow Transplantation volume 41, pages 109–117 (2008)Cite this article

Abstract

β-Thalassemia major and sickle cell disease (SCD) are among the most common hereditary disorders worldwide. The supportive treatment of β-thalassemia major requires chronic, life-long RBC transfusions, which cause progressive iron overload and the potential for impaired endocrine, cardiac and hepatic function. The phenotype of thalassemia major is reliably predicted by its genotype. In contrast, SCD is a variable genetic disease caused by a single amino acid substitution in the β chain of human hemoglobin. Manifestations of SCD are quite varied, but generally result from the tendency of Hb S to irreversibly polymerize under physiologic stressors such as hypoxemia and acidosis. The polymerization causes perturbations in the erythrocyte integrity that promote vaso-occlusion and which manifest as clinical events such as severe painful episodes, acute chest syndrome, splenic infarction, stroke and avascular necrosis of target joints. The only cure proved for these disorders is correction of the genetic defect by allogeneic hematopoietic cell transplantation (HCT). We illustrate the pediatric experience of HCT for hemoglobinopathies and discuss how these results affect future therapeutic decisions in children who inherit these disorders.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Lo L, Singer ST . Thalassemia: current approach to an old disease. Pediatr Clin North Am 2002; 49: 1165–1191, v.

    Article  Google Scholar 

  2. Urbinati F, Madigan C, Malik P . Pathophysiology and therapy for haemoglobinopathies; part II: thalassaemias. Expert Rev Mol Med 2006; 8: 1–26.

    Article  Google Scholar 

  3. Lucarelli G, Galimberti M, Polchi P, Angelucci E, Baronciani D, Giardini C et al. Bone marrow transplantation in patients with thalassemia. N Engl J Med 1990; 322: 417–421.

    Article  CAS  Google Scholar 

  4. Lucarelli G, Galimberti M, Giardini C, Polchi P, Angelucci E, Baronciani D et al. Bone marrow transplantation in thalassemia. The experience of Pesaro. Ann N Y Acad Sci 1998; 850: 270–275.

    Article  CAS  Google Scholar 

  5. Lucarelli G, Andreani M, Angelucci E . The cure of thalassemia by bone marrow transplantation. Blood Rev 2002; 16: 81–85.

    Article  CAS  Google Scholar 

  6. La Nasa G, Argiolu F, Giardini C, Pession A, Fagioli F, Caocci G et al. Unrelated bone marrow transplantation for beta-thalassemia patients: the experience of the Italian Bone Marrow Transplant Group. Ann N Y Acad Sci 2005; 1054: 186–195.

    Article  Google Scholar 

  7. Locatelli F, Rocha V, Reed W, Bernaudin F, Ertem M, Grafakos S et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 2003; 101: 2137–2143.

    Article  CAS  Google Scholar 

  8. Hongeng S, Pakakasama S, Chuansumrit A, Sirachainan N, Kitpoka P, Udomsubpayakul U et al. Outcomes of transplantation with related- and unrelated-donor stem cells in children with severe thalassemia. Biol Blood Marrow Transplant 2006; 12: 683–687.

    Article  Google Scholar 

  9. Gaziev D, Galimberti M, Lucarelli G, Polchi P, Giardini C, Angelucci E et al. Bone marrow transplantation from alternative donors for thalassemia: HLA-phenotypically identical relative and HLA-nonidentical sibling or parent transplants. Bone Marrow Transplant 2000; 25: 815–821.

    Article  CAS  Google Scholar 

  10. Gaziev J, Lucarelli G . Stem cell transplantation for hemoglobinopathies. Curr Opin Pediatr 2003; 15: 24–31.

    Article  Google Scholar 

  11. Lucarelli G, Andreani M, Angelucci E . The cure of the thalassemia with bone marrow transplantation. Bone Marrow Transplant 2001; 28 (Suppl 1): S11–S13.

    Article  Google Scholar 

  12. Boulad F, Giardina P, Gillio A, Kernan N, Small T, Brochstein J et al. Bone marrow transplantation for homozygous beta-thalassemia. The Memorial Sloan-Kettering Cancer Center experience. Ann N Y Acad Sci 1998; 850: 498–502.

    Article  CAS  Google Scholar 

  13. Lee YS, Kristovich KM, Ducore JM, Vichinsky E, Crouse VL, Glader BE et al. Bone marrow transplant in thalassemia. A role for radiation? Ann N Y Acad Sci 1998; 850: 503–505.

    Article  CAS  Google Scholar 

  14. Mentzer WC, Cowan MJ . Bone marrow transplantation for beta-thalassemia: the University of California San Francisco experience. J Pediatr Hematol Oncol 2000; 22: 598–601.

    Article  CAS  Google Scholar 

  15. Gluckman EG, Roch VV, Chastang C . Use of cord blood cells for banking and transplant. Oncologist 1997; 2: 340–343.

    CAS  PubMed  Google Scholar 

  16. Wagner JE, Kernan NA, Steinbuch M, Broxmeyer HE, Gluckman E . Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet 1995; 346: 214–219.

    Article  CAS  Google Scholar 

  17. Rocha V, Wagner Jr JE, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med 2000; 342: 1846–1854.

    Article  CAS  Google Scholar 

  18. Balduzzi A, Gooley T, Anasetti C, Sanders JE, Martin PJ, Petersdorf EW et al. Unrelated donor marrow transplantation in children. Blood 1995; 86: 3247–3256.

    CAS  PubMed  Google Scholar 

  19. Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993; 328: 593–602.

    Article  CAS  Google Scholar 

  20. Johnson FL, Look AT, Gockerman J, Ruggiero MR, Dalla-Pozza L, Billings III FT . Bone-marrow transplantation in a patient with sickle-cell anemia. N Engl J Med 1984; 311: 780–783.

    Article  CAS  Google Scholar 

  21. Giardini C, Lucarelli G . Bone marrow transplantation for beta-thalassemia. Hematol Oncol Clin North Am 1999; 13: 1059–1064, viii.

    Article  CAS  Google Scholar 

  22. Thomas ED, Storb R . Bone marrow transplantation for acute myelogenous leukemia. Lancet 1982; 2: 1408.

    Article  CAS  Google Scholar 

  23. Mentzer WC, Heller S, Pearle PR, Hackney E, Vichinsky E . Availability of related donors for bone marrow transplantation in sickle cell anemia. Am J Pediatr Hematol Oncol 1994; 16: 27–29.

    CAS  PubMed  Google Scholar 

  24. Walters MC, Patience M, Leisenring W, Eckman JR, Buchanan GR, Rogers ZR et al. Barriers to bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant 1996; 2: 100–104.

    CAS  PubMed  Google Scholar 

  25. Walters MC, Patience M, Leisenring W, Eckman JR, Scott JP, Mentzer WC et al. Bone marrow transplantation for sickle cell disease. N Engl J Med 1996; 335: 369–376.

    Article  CAS  Google Scholar 

  26. Platt OS . Sickle cell paths converge on hydroxyurea. Nat Med 1995; 1: 307–308.

    Article  CAS  Google Scholar 

  27. Walters MC, Storb R, Patience M, Leisenring W, Taylor T, Sanders JE et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood 2000; 95: 1918–1924.

    CAS  PubMed  Google Scholar 

  28. Vermylen C, Cornu G, Ferster A, Brichard B, Ninane J, Ferrant A et al. Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplant 1998; 22: 1–6.

    Article  CAS  Google Scholar 

  29. Bernaudin F, Socie G, Kuentz M, Chevret S, Duval M, Bertrand Y et al. Long-term results of related, myeloablative stem cell transplantation to cure sickle cell disease. Blood 2007.

  30. Vassiliou G, Amrolia P, Roberts IA . Allogeneic transplantation for haemoglobinopathies. Best Pract Res Clin Haematol 2001; 14: 807–822.

    Article  CAS  Google Scholar 

  31. Brichard B, Vermylen C, Ninane J, Cornu G . Persistence of fetal hemoglobin production after successful transplantation of cord blood stem cells in a patient with sickle cell anemia. J Pediatr 1996; 128: 241–243.

    Article  CAS  Google Scholar 

  32. Kurtzberg J, Laughlin M, Graham ML, Smith C, Olson JF, Halperin EC et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996; 335: 157–166.

    Article  CAS  Google Scholar 

  33. Wagner JE, Rosenthal J, Sweetman R, Shu XO, Davies SM, Ramsay NK et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 1996; 88: 795–802.

    CAS  PubMed  Google Scholar 

  34. Adamkiewicz TV, Szabolcs P, Haight A, Baker KS, Staba S, Kedar A et al. Unrelated cord blood transplantation in children with sickle cell disease: review of four-center experience. Pediatr Transplant 2007; 11: 641–644.

    Article  CAS  Google Scholar 

  35. Iannone R, Casella JF, Fuchs EJ, Chen AR, Jones RJ, Woolfrey A et al. Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia. Biol Blood Marrow Transplant 2003; 9: 519–528.

    Article  Google Scholar 

  36. Walters MC . Bone marrow transplantation for sickle cell disease: where do we go from here? J Pediatr Hematol Oncol 1999; 21: 467–474.

    Article  CAS  Google Scholar 

  37. Andreani M, Nesci S, Lucarelli G, Tonucci P, Rapa S, Angelucci E et al. Long-term survival of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation. Bone Marrow Transplant 2000; 25: 401–404.

    Article  CAS  Google Scholar 

  38. Nesci S, Manna M, Lucarelli G, Tonucci P, Donati M, Buffi O et al. Mixed chimerism after bone marrow transplantation in thalassemia. Ann N Y Acad Sci 1998; 850: 495–497.

    Article  CAS  Google Scholar 

  39. Sadelain M . Genetic treatment of the haemoglobinopathies: recombinations and new combinations. Br J Haematol 1997; 98: 247–253.

    Article  CAS  Google Scholar 

  40. Sadelain M . Recent advances in globin gene transfer for the treatment of beta-thalassemia and sickle cell anemia. Curr Opin Hematol 2006; 13: 142–148.

    Article  CAS  Google Scholar 

  41. Persons DA, Tisdale JF . Gene therapy for the hemoglobin disorders. Semin Hematol 2004; 41: 279–286.

    Article  CAS  Google Scholar 

  42. Quek L, Thein SL . Molecular therapies in beta-thalassaemia. Br J Haematol 2007; 136: 353–365.

    Article  CAS  Google Scholar 

  43. Rund D, Rachmilewitz E . Beta-thalassemia. N Engl J Med 2005; 353: 1135–1146.

    Article  CAS  Google Scholar 

  44. Braude P, Pickering S, Flinter F, Ogilvie CM . Preimplantation genetic diagnosis. Nat Rev Genet 2002; 3: 941–953.

    Article  CAS  Google Scholar 

  45. Fiorentino F, Biricik A, Karadayi H, Berkil H, Karlikaya G, Sertyel S et al. Development and clinical application of a strategy for preimplantation genetic diagnosis of single gene disorders combined with HLA matching. Mol Hum Reprod 2004; 10: 445–460.

    Article  CAS  Google Scholar 

  46. Kuliev A, Rechitsky S, Verlinsky O, Tur-Kaspa I, Kalakoutis G, Angastiniotis M et al. Preimplantation diagnosis and HLA typing for haemoglobin disorders. Reprod Biomed Online 2005; 11: 362–370.

    Article  CAS  Google Scholar 

  47. Qureshi N, Foote D, Walters MC, Singer ST, Quirolo K, Vichinsky EP . Outcomes of preimplantation genetic diagnosis therapy in treatment of beta-thalassemia: a retrospective analysis. Ann N Y Acad Sci 2005; 1054: 500–503.

    Article  Google Scholar 

  48. Van de Velde H, Georgiou I, De Rycke M, Schots R, Sermon K, Lissens W et al. Novel universal approach for preimplantation genetic diagnosis of beta-thalassaemia in combination with HLA matching of embryos. Hum Reprod 2004; 19: 700–708.

    Article  CAS  Google Scholar 

  49. Angelucci E, Muretto P, Lucarelli G, Ripalti M, Baronciani D, Erer B et al. Treatment of iron overload in the ‘ex-thalassemic’. Report from the phlebotomy program. Ann N Y Acad Sci 1998; 850: 288–293.

    Article  CAS  Google Scholar 

  50. Centis F, Gaziev J, Delfini C, Lucarelli G . Serum transferrin receptor levels in thalassemia after bone marrow transplantation. Bone Marrow Transplant 1993; 12 (Suppl 1): 111–114.

    PubMed  Google Scholar 

  51. Giardini C, Galimberti M, Lucarelli G, Polchi P, Angelucci E, Baronciani D et al. Desferrioxamine therapy accelerates clearance of iron deposits after bone marrow transplantation for thalassaemia. Br J Haematol 1995; 89: 868–873.

    Article  CAS  Google Scholar 

  52. Mariotti E, Angelucci E, Agostini A, Baronciani D, Sgarbi E, Lucarelli G . Evaluation of cardiac status in iron-loaded thalassaemia patients following bone marrow transplantation: improvement in cardiac function during reduction in body iron burden. Br J Haematol 1998; 103: 916–921.

    Article  CAS  Google Scholar 

  53. Olivieri NF . The beta-thalassemias. N Engl J Med 1999; 341: 99–109.

    Article  CAS  Google Scholar 

  54. De Sanctis V, Urso L . Growth and thalassemia. Minerva Pediatr 1997; 49: 121–128.

    CAS  PubMed  Google Scholar 

  55. Gaziev J, Galimberti M, Giardini C, Baronciani D, Lucarelli G . Growth in children after bone marrow transplantation for thalassemia. Bone Marrow Transplant 1993; 12 (Suppl 1): 100–101.

    PubMed  Google Scholar 

  56. Li CK, Chik KW, Wong GW, Cheng PS, Lee V, Shing MM . Growth and endocrine function following bone marrow transplantation for thalassemia major. Pediatr Hematol Oncol 2004; 21: 411–419.

    Article  CAS  Google Scholar 

  57. Eggleston B, Patience M, Edwards S, Adamkiewicz T, Buchanan GR, Davies SC et al. Effect of myeloablative bone marrow transplantation on growth in children with sickle cell anaemia: results of the multicenter study of haematopoietic cell transplantation for sickle cell anaemia. Br J Haematol 2007; 136: 673–676.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Supported in part by a grant from the Pediatric Cancer Research Foundation.

Author information

Authors and Affiliations

  1. Department of Pediatrics, Columbia University, New York, NY, USA

    M Bhatia

  2. Department of Pediatric Hematology/Oncology, Children's Hospital and Research Center, Oakland, CA, USA

    M C Walters

Authors
  1. M Bhatia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M C Walters
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M Bhatia.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bhatia, M., Walters, M. Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future. Bone Marrow Transplant 41, 109–117 (2008). https://doi.org/10.1038/sj.bmt.1705943

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705943

Keywords

This article is cited by

Search

Advanced search

Quick links